Ads
related to: peginterferon treatment- Find a Location
Get Directions To The James
Locations in Central Ohio
- Treat Cancer & Diagnose
The James is Home to
World-Renowned Cancer Experts
- Immunotherapy Management
Proactively mitigating side effects
Well-being beyond cancer treatment
- Find A Doctor
Browse The James Top Doctor By
Specialty, Cancer Type or Name
- Patient Support
Access to Information, Resource &
Activities Available to Support You
- New Diagnostic Center
Same or Next Day Access to
Cancer Diagnostic Experts
- Find a Location
Search results
Results From The WOW.Com Content Network
Peginterferon alfa-2a is a long acting interferon. Interferons are proteins released in the body in response to viral infections . Interferons are important for fighting viruses in the body, for regulating reproduction of cells , and for regulating the immune system.
A 2012 meta-analysis had found PEGylated interferon alfa-2a to be the more effective variant for treatment-naive patients. [10] With the advent of Direct-Acting-Antivirals (DAAs — ), interferon-based treatment regimens gradually fell out of fashion due to relatively poor efficacy and high frequency of adverse side-effects.
Pegylated interferon (PEG-IFN) is a class of medication that includes three different drugs as of 2012: [1]. Pegylated interferon-alpha-2a; Pegylated interferon-alpha-2b ...
Peginterferon beta-1a, sold under the brand name Plegridy, is medication used to treat multiple sclerosis. [4] [5]The most common side effects include headache, muscle pain, joint pain, influenza (flu)-like symptoms, pyrexia (fever), chills, asthenia (weakness), and erythema (reddening of the skin), pain or pruritus (itching) at the injection site.
Peginterferon-alfa may refer to: Peginterferon alfa-2a , an antiviral drug used in treatment for hepatitis C and hepatitis B Peginterferon alfa-2b , a treatment for hepatitis C
When used with the antiviral drug ribavirin, PEGylated interferon is effective in treatment of hepatitis C; at least 75% of people with hepatitis C genotypes 2 or 3 benefit from interferon treatment, although this is effective in less than 50% of people infected with genotype 1 (the more common form of hepatitis C virus in both the U.S. and ...